Bioventix PLC | Income Statement

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,706.40
3,535.40
4,333.20
5,517.20
7,245.90
8,751.60
Cost of Goods Sold (COGS) incl. D&A
188.30
302.90
320.50
494.90
494.90
573.20
Gross Income
2,518.10
3,232.50
4,012.80
5,022.30
6,751.00
8,178.40
SG&A Expense
706.90
822.00
396.10
178.70
301.30
1,313.80
EBIT
1,811.20
2,410.50
3,616.60
4,843.60
6,449.70
6,864.60
Unusual Expense
-
169.40
511.30
713.70
764.50
-
Non Operating Income/Expense
1.90
39.00
9.60
75.40
5.80
71.90
Pretax Income
1,821.40
2,230.60
3,105.70
4,218.90
5,746.50
6,826.50
Income Tax
299.90
415.20
548.20
724.50
824.20
1,163.10
Consolidated Net Income
1,521.50
1,815.40
2,557.50
3,494.40
4,922.30
5,663.30
Net Income
1,521.50
1,815.40
2,557.50
3,494.40
4,922.30
5,663.30
Net Income After Extraordinaries
1,521.50
1,815.40
2,557.50
3,494.40
4,922.30
5,663.30
Net Income Available to Common
1,521.50
1,815.40
2,557.50
3,494.40
4,922.30
5,663.30
EPS (Basic)
0.30
0.36
0.51
0.69
0.96
1.10
Basic Shares Outstanding
5,025.40
5,032.20
5,048.50
5,050.90
5,108.00
5,138.70
EPS (Diluted)
0.30
0.35
0.50
0.68
0.95
1.08
Diluted Shares Outstanding
5,025.40
5,126.70
5,136.20
5,142.70
5,198.00
5,228.60
EBITDA
1,855.60
2,441.40
3,662.20
4,885.30
6,489.10
6,923.10
Non-Operating Interest Income
12.00
28.60
10.00
13.70
55.60
33.80

About Bioventix

View Profile
Address
7 Romans Business Park
Farnham Surrey GU9 7SX
United Kingdom
Employees -
Website http://bioventix.com
Updated 07/08/2019
Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.